T1D Risk Assessment in Kids With Relatives

NACompletedINTERVENTIONAL
Enrollment

512

Participants

Timeline

Start Date

May 28, 2015

Primary Completion Date

May 17, 2019

Study Completion Date

May 17, 2019

Conditions
Type 1 Diabetes
Interventions
BIOLOGICAL

Analysis of early immune modifications

"* blood and stool sampling in parents during pregnancy (at enrollment, i.e. 7th-8th month of pregnancy)~* cord blood sampling~* stool sampling in mothers and newborns at birth (day 7)~* blood and stool sampling in children at the age of 8, 18, 30 and 42 months"

OTHER

Collection of clinical and socio-demographic data

"1. Questionnaire filled in by clinicians at enrollment and at birth~2. Self-administered questionnaire filled by parents at enrollment, at birth, and then at month 8, 18, 30 and 42"

Trial Locations (1)

75014

Cochin Hospital, Paris

All Listed Sponsors
collaborator

Institut National de la Santé et de la Recherche Médicale (INSERM) U1016 - Institut Cochin, Immunology of Diabetes Team, Paris, France

UNKNOWN

collaborator

INSERM U1153, Epidemiology Research Unit on Perinatal Health and Women and Children Health, Port-Royal Hospital, Paris, France

UNKNOWN

collaborator

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

OTHER

collaborator

Commissariat A L'energie Atomique

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02184676 - T1D Risk Assessment in Kids With Relatives | Biotech Hunter | Biotech Hunter